Skip to content

Multicenter Registry for Angiography-Derived Quantitative Flow Ratio

Multicenter Registry for Diagnostic Accuracy of Angiography-Derived Quantitative Flow Ratio to Evaluate the Hemodynamic Significance of Coronary Artery Stenosis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03791788
Acronym
QFRRegistry
Enrollment
524
Registered
2019-01-03
Start date
2016-04-30
Completion date
2023-12-31
Last updated
2024-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Heart Disease

Keywords

Stable angina, Acute Myocardial Infarction, Fractional Flow Reserve, Quantitative Flow Ratio

Brief summary

1. to investigate the feasibility and diagnostic performance of contrast quantitative flow ratio (QFR) for identifying the functional significance of intermediate degree stenotic lesions in all-comer patients with coronary artery disease (CAD) including presentation of acute myocardial infarction (AMI) with non-culprit lesion. 2. to compare the changes of contrast QFR and fractional flow reserve (FFR) according to severity of percent diameter stenosis (%DS) 3. to evaluate prognostic implication of contrast QFR in comparison with FFR

Detailed description

Despite potential clinical benefits and abundant evidences of FFR-guided percutaneous coronary intervention (PCI), adoption rate of FFR is still low in real world practice, most likely due to use of additional resource and to concern about side effects of hyperemic agent. Therefore, several tools to derive FFR non-invasively has been developed based on computational fluid dynamics to overcome the limitations. One of the novel methods, the contrast quantitative flow ratio (QFR) is a computation of FFR based on 3-dimensional quantitative coronary angiography (QCA) combined with Thrombolysis in Myocardial Infarction (TIMI) frame counts adjustment without hyperemic agent infusion. Although diagnostic performance of contrast QFR for evaluation of functional significance, using FFR as reference standard, is well validated in patients with stable ischemic heart disease (SIHD), there have been lack of evidence regarding the reliability of QFR for non-culprit stenosis in patients with AMI. Therefore, the investigators sought to investigate the feasibility and diagnostic performance of contrast QFR for identifying the functional significance of coronary stenosis in all-comer patients with CAD. In addition, prognostic implication of contrast QFR will be also compared with that of FFR.

Interventions

DIAGNOSTIC_TESTQFR assessment

QFR measurement in order to evaluate functional significance of epicardial stenosis and to compare the response of QFR for worsening stenosis severity, FFR value as reference standard

Sponsors

Seoul National University Hospital
CollaboratorOTHER
Inje University
CollaboratorOTHER
Dongsan Medical Center
CollaboratorOTHER
Chosun University Hospital
CollaboratorOTHER
Samsung Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Subject must be ≥18 years * Patients suspected with ischemic heart disease * Patients with intermediate degree of coronary artery stenosis (40-70% stenosis by visual estimation) in major epicardial coronary artery with FFR measurement * Patients who were able to analyze QFR * Subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of receiving invasive physiologic evaluation and he/she or his/her legally authorized representative provides

Exclusion criteria

* Left main (LM) or right coronary artery (RCA) ostial lesion * Severe overlap of stenotic segments * Severe tortuosity of target vessel * Poor angiographic image quality precluding contour detection * No optimal images with angles ≥ 25o

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic accuracy of QFRthrough study completion, an average of 6 monthsDiagnostic accuracy of contrast QFR to predict FFR lower than 0.8
Vessel-related composite outcomethrough study completion, an average of 2 yeara composite of cardiac death, vessel-related myocardial infarction, and vessel-related ischemia driven revascularization

Secondary

MeasureTime frameDescription
Sensitivity of QFRthrough study completion, an average of 6 monthsSensitivity of contrast QFR to predict FFR lower than 0.8
Specificity of QFRthrough study completion, an average of 6 monthsSpecificity of contrast QFR to predict FFR lower than 0.8
Correlation between QFR and FFRthrough study completion, an average of 6 monthsCorrelation between QFR and FFR

Other

MeasureTime frameDescription
Pre-specified substudy of exercise duration after PCIthrough study completion, an average of 3 monthsresidual functional SYNTAX score calculated using post-PCI QFR will be used to define functional complete revascularization. Pre- and Post-PCI exercise treadmill test within 3 months window from PCI

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026